Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 1
2019 5
2020 4
2021 6
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
Luijten MMW, van Weelden WJ, Lalisang RI, Bulten J, Lindemann K, van Beekhuizen HJ, Trum H, Boll D, Werner HMJ, van Lonkhuijzen LRCW, Yigit R, Krakstad C, Witteveen PO, Galaal K, van Ginkel AA, Bignotti E, Weinberger V, Sweegers S, Eriksson AGZ, Keizer DM, van de Stolpe A, Romano A, Pijnenborg JMA, European Network For Individualized Treatment In Endometrial Cancer. Luijten MMW, et al. Among authors: van weelden wj. Cancers (Basel). 2024 May 30;16(11):2084. doi: 10.3390/cancers16112084. Cancers (Basel). 2024. PMID: 38893205 Free PMC article.
Author reply.
van Weelden WJ, Birkendahl PB, Lalisang RI, Inthout J, Kruitwagen RFPM, Romano A, Pijnenborg JMA. van Weelden WJ, et al. BJOG. 2024 Feb;131(3):382-383. doi: 10.1111/1471-0528.17676. Epub 2023 Oct 9. BJOG. 2024. PMID: 37814390 No abstract available.
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, Gil-Moreno A, Boll D, Vos MC, van Altena AM, Asberger J, Sweegers S, van Weelden WJ, van der Putten LJM, Amant F, Visser NCM, Snijders MPLM, Küsters-Vandevelde HVN, Kruitwagen R, Matias-Guiu X, Weinberger V, Reijnen C, Pijnenborg JMA. Vrede SW, et al. Among authors: van weelden wj. JAMA Netw Open. 2022 Dec 1;5(12):e2247372. doi: 10.1001/jamanetworkopen.2022.47372. JAMA Netw Open. 2022. PMID: 36525269 Free PMC article.
[Fertility sparing treatment of endometrial carcinoma].
Luijten MMW, van Weelden WJ, de Kroon CD, Pijnenborg JMA, van Gent MDJM. Luijten MMW, et al. Among authors: van weelden wj. Ned Tijdschr Geneeskd. 2021 Nov 25;165:D5765. Ned Tijdschr Geneeskd. 2021. PMID: 35129891 Dutch.
Recurrent Endometrial Cancer: Local and Systemic Treatment Options.
Rütten H, Verhoef C, van Weelden WJ, Smits A, Dhanis J, Ottevanger N, Pijnenborg JMA. Rütten H, et al. Among authors: van weelden wj. Cancers (Basel). 2021 Dec 14;13(24):6275. doi: 10.3390/cancers13246275. Cancers (Basel). 2021. PMID: 34944893 Free PMC article. Review.
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ, Lalisang RI, Bulten J, Lindemann K, van Beekhuizen HJ, Trum H, Boll D, Werner HMJ, van Lonkhuijzen LRCW, Yigit R, Forsse D, Witteveen PO, Galaal K, van Ginkel A, Bignotti E, Weinberger V, Sweegers S, Kroep JR, Cabrera S, Snijders MPLM, Inda MA, Eriksson AGZ; European Network for Individualized Treatment in Endometrial Cancer; Krakstad C, Romano A, van de Stolpe A, Pijnenborg JMA. van Weelden WJ, et al. Am J Obstet Gynecol. 2021 Oct;225(4):407.e1-407.e16. doi: 10.1016/j.ajog.2021.05.007. Epub 2021 May 19. Am J Obstet Gynecol. 2021. PMID: 34019887 Free article.
22 results